It promotes programmed death-ligand 1 (PD-L1) expression via the Janus Kinase/signal transducer and activator of transcription 1 (JAK–STAT1) pathway in both tumor and immune cells, contributing to immune evasion and reduced cytotoxic T cell activity [57,66]. The gene discussed is STAT1; the disease is neoplasm.